Skip to main content
Clinical Trials/CTRI/2020/11/029083
CTRI/2020/11/029083
Not yet recruiting
Phase 2

RANDOMIZED CONTROLLED CLINICAL TRIAL OF EFFICACY OF PASHANBHEDADI GHANVATI IN THE MANAGEMENT OF VAATASHTHILA W.S.R. TO BENIGN PROSTATE HYPERPLASIA

Preeti Bhalke0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Preeti Bhalke
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Preeti Bhalke

Eligibility Criteria

Inclusion Criteria

  • Patients having prostate size 30 to 100 gram
  • Patients having post void residual volume 50 to 200 ml
  • Patients willing to participate in study
  • Patients having mild 1 to 7 moderate 8 to 19 international prostate symptom score
  • Patients with severe 20 to 35 international prostate symptom score with no other consequences of benign prostate Hyperplasia and reluctant for surgery

Exclusion Criteria

  • Patients of malignant prostatic enlargement or prostatitis or uremia septicemia or renal failure
  • Patients having other urological pathologies like nephrotic syndrome or glomerulo nephritis or chronic kidney diseases etc
  • Increased serum creatinine and blood urea
  • Patients having HIV or HBsAg or major systemic disorders like uncontrolled HTN or DM or PTB etc
  • Patients participating in other clinical trials
  • Patients having hematuria
  • Patients with acute urine retention which needs surgical intervention
  • Patients currently using any other form of medicle therapy for benign prostate hyperplasia

Outcomes

Primary Outcomes

Not specified

Similar Trials